{{Rsnum
|rsid=2029253
|Gene=ALOX5
|Chromosome=10
|position=45891484
|Orientation=plus
|GMAF=0.4298
|Gene_s=ALOX5
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 43.4 | 11.5
| HCB | 20.4 | 47.4 | 32.1
| JPT | 21.4 | 45.5 | 33.0
| YRI | 61.2 | 31.3 | 7.5
| ASW | 51.8 | 37.5 | 10.7
| CHB | 20.4 | 47.4 | 32.1
| CHD | 10.2 | 49.1 | 40.7
| GIH | 51.5 | 41.6 | 6.9
| LWK | 49.5 | 42.2 | 8.3
| MEX | 25.9 | 44.8 | 29.3
| MKK | 35.9 | 53.8 | 10.3
| TSI | 35.3 | 47.1 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23079278
|Title=Genetic variation in members of the leukotrienes biosynthesis pathway confers risk of ischemic stroke in Eastern Han Chinese
}}

{{PMID Auto
|PMID=23324273
|Title=Association between genetic variants of the leukotriene biosynthesis pathway and the risk of stroke: a case-control study in the Chinese Han population
}}

{{PMID Auto
|PMID=18296645
|Title=Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
|OA=1
}}

{{PMID Auto
|PMID=18398223
|Title=Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study.
}}

{{PMID Auto
|PMID=19130089
|Title=Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=19214143
|Title=5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}